Related Experiment Video

Updated: Aug 10, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

SAGE and related approaches for cancer target identification

Dale Porter1, Jun Yao, Kornelia Polyak

  • 1Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.

Drug Discovery Today
|March 15, 2006
PubMed

Insights

Serial Analysis of Gene Expression (SAGE) and similar techniques offer powerful genomic insights for cancer research. These methods aid in discovering diagnostic markers, therapeutic targets, and understanding tumor progression.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Genetic, epigenetic, and transcriptional analyses are crucial for identifying cancer markers and therapeutic targets.
  • Numerous candidate markers and targets have been discovered through comprehensive profiling of normal and cancerous tissues.
  • Understanding cancer mechanisms requires advanced genomic technologies.

Purpose of the Study:

  • To provide an overview of Serial Analysis of Gene Expression (SAGE) and SAGE-like techniques.
  • To highlight the utility and advantages of SAGE-like methods for drug target discovery.
  • To summarize recent profiling studies and their implications for cancer research.

Main Methods:

  • Overview of Serial Analysis of Gene Expression (SAGE) and SAGE-like techniques.
  • Review of comprehensive genomic profiling studies.
  • Analysis of data from normal and cancerous tissues and cells.

Main Results:

  • SAGE and SAGE-like techniques are valuable for discovering diagnostic, predictive, and prognostic markers.
  • These methods offer advantages over other genomic technologies for identifying drug targets.
  • Recent studies provide insights into tumor initiation, progression, and the tumor microenvironment.

Conclusions:

  • SAGE and SAGE-like techniques are essential tools in cancer research for marker and target discovery.
  • These methods enhance the molecular understanding of cancer and reveal new therapeutic avenues.
  • Comprehensive genomic profiling advances personalized medicine in oncology.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...